SAN DIEGO, June 26, 2024 /PRNewswire/ — Ingredient Biosciences, Inc., a developer of pioneering applied sciences to empower science, at present introduced the additions of two industry-leading synthetic intelligence and portfolio administration consultants to its govt staff. The appointments will construct Ingredient’s management because it expands with modern merchandise and capabilities.
Ingredient is happy to announce the appointment of Amirali Kia, PhD, as Vice President of Synthetic Intelligence. Dr. Kia will apply his in depth experience in Synthetic Intelligence throughout the Life Sciences sector to boost the worth of Ingredient’s present and future merchandise. His function will embody optimizing the utility of the excellent multi-omic datasets generated by Aviti24.
Ingredient can also be appointing Tina Tian, PhD, as Vice President of Portfolio Administration. Since launching Aviti in 2022, Ingredient has frequently launched new kits and chemistries, driving innovation and robust differentiation for its merchandise. Dr. Tian will proceed Ingredient’s relentless drive, taking cost of program and portfolio administration.
“The important thing to Ingredient’s success and market progress is our passionate and high-performing staff who pushes the boundary of improvements. The experience Amirali and Tina deliver to Ingredient will expedite our work to offer modern merchandise for the way forward for biology,” stated Molly He, CEO, Ingredient Biosciences. “We are going to proceed to redefine what is feasible on a sequencer and assist labs across the globe shift their science into the next gear.”
About Amirali Kia, PhD, Vice President of Synthetic Intelligence
Amirali brings over 12 years of experience in making use of machine studying and information science to biology and biotechnology. He has revealed quite a few articles within the fields of machine studying and computational biology.
Earlier than becoming a member of Ingredient Biosciences, he served because the Vice President of AI and Information Science at Deepcell, the place he helped develop the corporate’s AI analysis initiatives in cell morphology. Previous to this, he was the Vice President of AI and Computational Biology at Harbinger Well being, the place he performed a pivotal function in establishing the AI infrastructure and creating algorithms for early most cancers detection in blood samples.
Amirali started his industrial profession at Illumina following the completion of his PhD. Because the Director of the Core-AI staff, he efficiently harnessed AI for varied core applied sciences at Illumina, starting from instrument evaluation algorithms to protein engineering. His in depth industrial expertise encompasses instruments and devices, giant molecule discovery, and diagnostics.
Amirali holds a PhD from Stanford College in Excessive Efficiency Computing, with a concentrate on its purposes in biology.
About Tina Tian, PhD, Vice President of Portfolio Administration
Tina brings over 25 years of administration expertise within the biotech {industry} throughout the areas of portfolio administration, program administration, R&D and CLIA laboratory administration.
Previous to becoming a member of Ingredient, Tina was the Head of Pharma Companies at Roche Diagnostics, main a cross-functional CLIA staff to offer cutting-edge medical providers to pharma prospects. Earlier than becoming a member of Roche, Tina was a Senior Director of Portfolio and Program Administration at Thermo Fisher Scientific’s Medical Sequencing Division, the place she performed a pivotal function in constructing product roadmaps, establishing a PMO staff in addition to delivering merchandise to prospects. Tina’s expertise additionally contains senior PMO roles at Pacific Biosciences and Affymetrix.
Tina holds a Ph.D. in Biochemistry from the Johns Hopkins Medical College and obtained her postdoctoral coaching from the Nationwide Institutes of Well being.
About Ingredient Biosciences, Inc.
Ingredient Biosciences is a pioneering life science firm democratizing entry to superior organic instruments, driving impactful discoveries to learn humanity. We’re centered on creating disruptive DNA sequencing and multi-omics know-how for analysis markets. By way of innovating each basic factor of a organic assay system, Ingredient empowers prospects with reasonably priced, high-quality information and an improved person expertise, which in flip will speed up scientific discoveries. To study extra about Ingredient, please go to www.elementbiosciences.com and observe us on LinkedIn, X (Twitter), and Fb.
Media Contact:
Melissa Musiker
Ingredient Biosciences
[email protected]
SOURCE Ingredient Biosciences
